 Vanguard Group Inc. lifted its position in Ionis Pharmaceuticals Inc NASDAQ:IONS by 2.1 in the 2nd quarter, according to the company in its most recent disclosure with the Securities Exchange Commission. The fund owned 12,306,251 shares of the companys stock after purchasing an additional 252,690 shares during the quarter. Vanguard Group Inc. owned about ... 